This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.15 to $32.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The option becomes exercisable in three annual installments: 33,000 vesting on 10/5/2012, 33,000 vesting on 10/5/2013 and 34,000 vesting on 10/5/2014.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. Alkermes plc next reports earnings on October 28, 2013.
To receive a free e-mail notification whenever Alkermes plc makes a similar move, sign up!